Muruganantham Lillimary Eniya

Ms. Muruganantham Lillimary Eniya

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
PKPriya Kannian
Priya Kannian
MEMuruganantham Lillimary Eniya
Muruganantham Lillimary Eniya
PMPasuvaraj Mahanathi
Pasuvaraj Mahanathi
AGArul Gracemary
Arul Gracemary
NKNagalingeswaran Kumarasamy
Nagalingeswaran Kumarasamy
SCStephen Challacombe
Stephen Challacombe
Background and Objectives: SARS-CoV-2 infection initiates at mucosal surfaces, and mucosal immunity may influence the nature and severity of infection. Little is known about the induction of mucosal immunity by vaccination in COVID-19 convalescents. Methods: Sera from 205 healthcare workers were collected one month after the first Covishield vaccination and 1/3/6 months after the second vaccination, while paired sera and stimulated whole-mouth fluid (SWMF) was collected 1/3/6 months after the third vaccination (N = 10) and at 0/30/90 days after a COVID-19 episode (N = 8). Anti-SARS-CoV-2 spike antibody detection by ECLIA/ELISA and cytokine detection by ELISA/CBA were performed. Results: One month post-second vaccination, serum antibodies had increased significantly (6-fold) in the COVID-19-naïve group (CNG) but declined (1.5-fold) in the previously COVID-19-exposed group (CEG), who already had high antibody titres. The serum regulatory cytokine IL-10 levels were higher after three antigen exposures (p = 0.0002). New infections (breakthrough infections—BTIs) or reinfections (RIs) with asymptomatic/mild disease occurred in 44% of the CNG and 27% of the CEG (p < 0.01). The mucosal cytokine IL-17 levels were significantly higher in the CEG. Salivary IgG/IgA and secretory IgA antibodies were detectable both after vaccination and COVID-19. Innate cytokines (MIG, MCP-1, IL-8, IL-1β) were higher and sustained in SWMF in contrast to serum. Conclusions: Two vaccinations in the CNG resulted in an antibody boost, but the second vaccination in the CEG induced antibody anergy. Serum/mucosal antibodies declined by six months after vaccination, but the rapid increase at subsequent exposures were indicative of a good T cell/B cell memory response to SARS-CoV-2. A higher percentage of BTI among the CNG than RI among the CEG may indicate better protection due to higher antibody responses in the latter group.

28 April 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
AJAlbert Judith
Albert Judith
MEMuruganantham Lillimary Eniya
Muruganantham Lillimary Eniya
FBFaith Beulah
Faith Beulah
PSPoongulali Selvamuthu
Poongulali Selvamuthu
RYRamamurthy Silamban Yazhini
Ramamurthy Silamban Yazhini
PKPriya Kannian
Priya Kannian
Background/Objectives: Induction of anti-SARS-CoV-2 antibodies by COVID-19 vaccination reduces morbidity and mortality, but immune responses may be compromised in people living with HIV (PLWH). The aims of the current study were to determine whether viral suppression (VS) or immune reconstitution (IR) in PLWH directly affected their ability to produce effective levels of anti-SARS-CoV-2 antibodies in mucosal secretions or blood induced by vaccination. Methods: Anti-SARS-CoV-2 spike IgG, IgA and secretory IgA (SIgA) antibodies and their avidities were measured by ELISA in HIV-negative healthy controls (HC; n=49) and PLWH (n=94) using stimulated oral fluid (SOF) and serum. Frequencies of CD4/CD8 T cells and their expression of exhaustion/senescence were determined by flow cytometry. Cytokine levels were measured by cytokine bead arrays. Results: We showed that higher HIV burden negatively impacted the levels of systemic and mucosal anti-SARS-CoV-2 spike IgG antibodies produced. This differential IgG antibody production was unaffected by the IR status, antiretroviral therapy duration or by T cell exhaustion/senescence. PLWH elicited higher anti-SARS-CoV-2 spike IgA antibodies both in peripheral blood and oral mucosa, and secretory IgA (SIgA) antibodies in the oral mucosa. PLWH with higher HIV burdens elicited lower IgG avidity but the IgA avidity indices remained unaffected. PLWH expressed higher levels of innate immunity cytokines irrespective of the HIV burden in the oral mucosa. Conclusions: Significantly fewer breakthrough infections in PLWH compared with HC, along with high IgA/SIgA antibodies and increased innate immunity cytokines in the SOF suggests a potential role for mucosal immunity in the immunopathogenesis of COVID-19.

30 May 2026 in Vaccines
Verified
Journal Article
Open access
PDF file
AJAlbert Judith
Albert Judith
MEMuruganantham Lillimary Eniya
Muruganantham Lillimary Eniya
FBFaith Beulah
Faith Beulah
PSPoongulali Selvamuthu
Poongulali Selvamuthu
RYRamamurthy Silamban Yazhini
Ramamurthy Silamban Yazhini
PKPriya Kannian
Priya Kannian
Background/Objectives: The induction of anti-SARS-CoV-2 antibodies by COVID-19 vaccination reduces morbidity and mortality, but immune responses may be compromised in people living with HIV (PLWH). The aims of the current study were to determine whether viral suppression (VS) or immune reconstitution (IR) in PLWH directly affected their ability to produce effective levels of anti-SARS-CoV-2 antibodies in mucosal secretions or blood induced by vaccination. Methods: Anti-SARS-CoV-2 spike IgG, IgA and secretory IgA (SIgA) antibodies and their avidities were measured by ELISA in HIV-negative healthy controls (HC; n = 49) and PLWH (n = 94) using stimulated oral fluid (SOF) and serum. Frequencies of CD4/CD8 T cells and their expression of exhaustion/senescence were determined by flow cytometry. Cytokine levels were measured by cytokine bead arrays. Results: We showed that higher HIV burden negatively impacted the levels of systemic and mucosal anti-SARS-CoV-2 spike IgG antibodies produced. This differential IgG antibody production was unaffected by IR status, antiretroviral therapy duration or T cell exhaustion/senescence. PLWH elicited higher anti-SARS-CoV-2 spike IgA antibodies both in peripheral blood and oral mucosa and highr secretory IgA (SIgA) antibodies in the oral mucosa. PLWH with higher HIV RNA copies elicited lower IgG avidity but the IgA avidity indices remained unaffected. PLWH expressed higher levels of innate immunity cytokines in the oral mucosa, irrespective of the HIV RNA copies. Conclusions: Significantly fewer breakthrough infections in PLWH compared with HC, along with high IgA/SIgA antibodies and increased innate immunity cytokines in the SOF, suggest a potential role for mucosal immunity in the immunopathogenesis of COVID-19.

25 June 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
PKPriya Kannian
Priya Kannian
MEMuruganantham Lillimary Eniya
Muruganantham Lillimary Eniya
PMPasuvaraj Mahanathi
Pasuvaraj Mahanathi
AGArul Gracemary
Arul Gracemary
NKNagalingeswaran Kumarasamy
Nagalingeswaran Kumarasamy
SCStephen Challacombe
Stephen Challacombe
Background & Objectives: SARS-CoV2 infection initiates at mucosal surfaces and mucosal immunity may influence the nature and severity of infection. Little is known about their induction by vaccination in COVID-19 convalescents. Methods: Sera from 205 healthcare workers was collected one-month after first Covishield vaccination and 1/3/6-months after second vaccination, while paired sera and stimulated whole mouth fluid (SWMF) was collected 1/3/6-months after third vaccination (N=10) and at 0/30/90-days after a COVID-19 episode (N=8). All were tested for anti-SARS-CoV2 spike antibodies by ECLIA/ELISA and cytokines by ELISA/CBA. Results: One-month post-second-vaccination, serum antibodies had increased significantly (6-fold) in the COVID-19-naïve group (CNG), but declined (1.5-fold) in the previously COVID-19-exposed group (CEG), who already had high antibody titres. The serum regulatory cytokine IL-10 levels were higher after three antigen exposures (p=0.0002). New infections or reinfections occurred in 44% of CNG and 27% of CEG (p< 0.01). The mucosal cytokine IL-17 levels were significantly higher in the CEG. Salivary IgG/IgA and secretory IgA antibodies were detectable both after vaccination and COVID-19. Adaptive immunity cytokines after three vaccinations were barely detectable. Innate cytokines (MIG, MCP-1, IL-8, IL-1β) were higher and sustained in SWMF in contrast to serum. Conclusions: Two vaccinations in CNG resulted in an expected antibody boost, but that a second vaccination in CEG induced antibody anergy. Rapidly declining serum antibodies and minimal T cell cytokines raise concerns over their durability in subsequent virus exposures. Sustained innate cytokines and IgA antibodies emanating from the oral mucosa may result in early virus clearance and impact morbidity.

17 September 2026 in Viruses
Verified
Journal Article
Open access
PDF file
MEMuruganantham Lillimary Eniya
Muruganantham Lillimary Eniya
SNShervin Dokht Sadeghi Nasab
Shervin Dokht Sadeghi Nasab
AJAlbert Judith
Albert Judith
FCFrederick Clasen
Frederick Clasen
FBFaith Beulah
Faith Beulah
PKPriya Kannian
Priya Kannian
The entry of SARS-CoV-2 via the mucosal surfaces of the upper respiratory tract, including the oral cavity, may be influenced by innate and adaptive immunity. We aimed to determine whether antibodies in secretions might influence the SARS-CoV-2 burden and thus the severity of infection. Blood and stimulated oral fluid (SOF) samples were collected at recruitment (d0) from 173 participants and sequentially at d14, d30 and d90 from 52 participants. Anti-SARS-CoV-2 spike antibodies of the IgG, IgA and SIgA isotypes were detected by ELISA. SARS-CoV-2 RNA copies were quantified by RT-PCR. SARS-CoV-2 RNA copies became negative by d14 in most subjects. At d14, 5/18 SOF samples continued to be RT-PCR-positive. Serum/SOF IgG antibodies were detected in all patients; IgG/IgA/SIgA antibodies increased by d14 and decreased by d90. At d0 and d14, SOF RNA copies were negatively correlated with SOF/serum IgG and with SOF IgA/SIgA antibodies. Higher SOF antibodies were significantly associated with a more rapid decline in SARS-CoV-2 burden. SARS-CoV-2 RNA copies and spike-specific antibodies showed differential trends during the major and minor COVID-19 waves in India. Avidity indices for SOF IgG/IgA antibodies declined by d90. Taken together, our data suggest a potential functional role for SOF anti-SARS-CoV-2 spike antibodies in clearing SARS-CoV-2 from the oral mucosa.

6 August 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
MEMuruganantham Lillimary Eniya
Muruganantham Lillimary Eniya
SNShervin Dokht Sadeghi Nasab
Shervin Dokht Sadeghi Nasab
AJAlbert Judith
Albert Judith
FCFrederick Clasen
Frederick Clasen
FBFaith Beulah
Faith Beulah
PKPriya Kannian
Priya Kannian
Entry of SARS-CoV-2 via mucosal surfaces of the upper respiratory tract including the oral cavity may be influenced by innate and adaptive immunity. We aim to determine whether antibodies in secretions might influence the SARS-CoV-2 burden and thus the severity of infection. Blood and stimulated oral fluid (SOF) samples were collected at recruitment (d0) from 173 patients, and sequentially at d14, d30 and d90 from 52 SARS-CoV-2 RT-PCR-confirmed patients. Anti-SARS-CoV-2 spike antibodies of IgG, IgA and SIgA isotypes were detected by ELISA. SARS-CoV-2 RNA copies were quantified by RT-PCR. SARS-CoV-2 RNA copies become negative by d14 in most subjects. At d14, 5/18 SOF samples continued to be RT-PCR positive. Serum/SOF IgG antibodies were detected in all patients; IgG/IgA/SIgA antibodies increased by d14 and decreased by d90. At d0 and d14, SOF RNA copies were negatively correlated with SOF/serum IgG and with SOF IgA/SIgA antibodies. Higher SOF antibodies were significantly associated with a more rapid decline in SARS-CoV-2 burden. SARS-CoV-2 RNA copies and spike-specific antibodies show differential trends during the major and minor COVID-19 waves in India. Avidity indices for SOF IgG/IgA antibodies declined by d90. Taken together our data suggests a potential functional role for SOF anti-SARS-CoV-2 spike antibodies in reducing the SARS-CoV-2 burden.